Rotavirus vaccines;Vaccinations antirotavirus

Archives de Pediatrie

Volumn 6, Issue 9, 1999, Pages 979-984

  Schmitz, J ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Infantile diarrhea; Rotavirus; Rotavirus infections; Vaccination

Indexed keywords

ROTAVIRUS VACCINE;

CHILD; FRANCE; HUMAN; INFANTILE DIARRHEA; INFECTION PREVENTION; MORBIDITY; MORTALITY; REVIEW; ROTAVIRUS; VACCINATION; VIRUS INFECTION;

EID: 0033178051     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(99)80593-4     Document Type: Article

References (17)

1. Kapikian AZ, Flores J, Hoshino Y, Glass RI, Midthun K, Gorziglia M, et al. Rotavirus: The major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination. J Infect Dis 1986; 153 : 815-22.
2. Unicomb LE, Kilgore PE, Faruque ASG, Hamadani JD, Fuchs GJ, Albert MJ, et al. Anticipating rotavirus vaccines: Hospital-based surveillance for rotavirus diarrhea and estimates of disease burden in Bangladesh. Pediatr Infect Dis 1997; 16 : 947-51.
3. Glass RI, Kilgore PE, Holman RC, Jin S, Smith JC, Woods PA, et al. The epidemiology of rotavirus diarrhea in the United States: Surveillance and estimates of disease burden. J Infect Dis 1996; 174 Suppl 1 : 5-11.
4. Desenclos JC, Rebiere I, Letrillard L, Flahault A, Hubert B. Diarrhea related morbidity and rotavirus infection in France. Acta Paediatr 1999; Suppl 425 : 42-7.
5. Blacklow NR, Greenberg HB. Viral gastroenteritis. N Engl J Med 1991; 325 : 252-64.
6. Vesikari T. Rotavirus vaccines against diarrheal disease. Lancet 1997; 350 : 1538-41.
7. Kapikian AZ, Hoshino Y, Chanock RM, Perez-Schael I. Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J Infect Dis 1996; 174 Suppl 1 : 65-72.
8. Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, et al. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med 1996; 335 : 1022-8.
9. Ward RL. Mechanisms of protection against rotavirus in humans and mice. J Infect Dis 1996; 174 Suppl 1 : 51-8.
10. Vesikari T, Kapikian AZ, Delem A, Zissis G. A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children. J Infect Dis 1986; 153 : 832-9.
11. Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Pichichero ME, Zito ET, et al. Safety and efficacy of high-dose rhesushuman reassortant rotavirus vaccines. Report of the National Multicenter Trial. Pediatrics 1996; 97 : 7-13.
12. Joensuu J, Koskenniemi E, Pang XL, Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 1997; 350 : 1205-9.
13. Lanata CF, Midthun K, Black RE, Butron B, Huapaya A, Penny ME, et al. Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. J Infect Dis 1996; 174 : 268-75.
14. Perez-Schael I, Guntinas MJ, Perez M, Pagone V, Rojas AM, Gonzalez R, et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med 1997; 337 : 1181-7.
15. Rennels MB. Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines. J Infect Dis 1996; 174 Suppl 1 : 107-11.
16. Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA 1998; 279 : 1371-6.
17. Keusch GT, Cash RA. A vaccine against rotavirus. When is too much too much? N Engl J Med 1997; 337 : 1228-9.